Benzyl-Spacer-Engineered Prodrug: Enabling NIR Fluorescent Activation for Cancer Therapy in a Zebrafish Gallbladder...

Area of Science:

• Biomedical Engineering
• Organic Chemistry
• Cancer Research

Background:

• Previous molecular designs for cancer theranostics faced limitations in tissue penetration and specificity.
• Developing targeted drug delivery systems with real-time monitoring capabilities is crucial for effective cancer treatment.

Purpose of the Study:

• To synthesize and characterize a novel near-infrared (NIR) prodrug, INM-Gem, for enhanced cancer therapy and diagnostics.
• To evaluate the improved tissue penetration, reduced background interference, and increased specificity of INM-Gem compared to its predecessor.
• To demonstrate the dual functionality of INM-Gem for simultaneous drug delivery and real-time imaging.

Main Methods:

• Synthesis and characterization of the NIR prodrug INM-Gem incorporating a benzyl linker.
• Comparative studies of INM-Gem's tissue penetration, background signal, and specificity in biological systems (e.g., zebrafish).
• Assessment of gemcitabine release and NIR fluorescence activation (at 673 nm) upon chemical activation.

Main Results:

• INM-Gem demonstrated superior tissue penetration and specificity with reduced background signal compared to the previous probe.
• Chemical activation of INM-Gem led to the concurrent release of gemcitabine and "turn-on" NIR fluorescence.
• The probe facilitated sensitive, real-time monitoring of drug release.

Conclusions:

• INM-Gem represents a significant advancement in cancer theranostics, offering improved drug delivery and imaging capabilities.
• The benzyl spacer plays a key role in enabling NIR-responsive drug activation and release.
• INM-Gem serves as a robust platform for precise bioimaging and targeted cancer therapy, highlighting its potential in biomedical research.